Abstract Anticancer peptides (ACPs) are emerging as a promising frontier in oncology, offering a novel approach to cancer treatment that is both targeted and versatile. Unlike traditional therapies that often damage healthy tissue, ACPs selectively attack cancer cells through mechanisms such as membrane disruption, apoptosis induction, and immune modulation. Derived from natural sources or engineered […]
Abstract As antimicrobial resistance rises globally, antimicrobial peptides (AMPs) offer a powerful alternative to traditional antibiotics. However, synthesizing these peptides—especially long and hydrophobic ones—has been both environmentally taxing and technically challenging due to the limitations of standard Solid Phase Peptide Synthesis (SPPS). This blog explores a novel, sustainable approach that modifies the SPPS workflow using […]
Abstract As the demand for peptide-based therapeutics grows, so too does the need for sustainable manufacturing methods. Traditional solid-phase peptide synthesis (SPPS), typically performed in the C-to-N direction, has long dominated the field—but it comes at a high environmental cost, consuming large amounts of reagents, solvents, and energy. In contrast, N-to-C peptide synthesis, a method […]
Abstract As global demographics shift toward an aging population, the burden of age-related diseases continues to grow—especially metabolic disorders like Type 2 diabetes and chronic pancreatitis. At the heart of these conditions lies a common issue: the gradual decline in pancreatic cell function due to aging. Recent scientific investigations have turned their attention to Pancragen, […]
Abstract Thymalin is a biologically active peptide complex derived from the thymus, known for its powerful role in supporting and regulating the immune system. As researchers continue to explore natural compounds that enhance immune function, Thymalin has emerged as a promising candidate—especially in the context of viral infections like COVID-19, where immune suppression plays a […]
Abstract This blog explores the critical roles of leptin and ghrelin — two key hormones that regulate appetite and energy balance — and how their dysfunction contributes to obesity. Leptin, produced by fat cells, signals satiety, while ghrelin, secreted by the stomach, stimulates hunger. In individuals with obesity, leptin resistance prevents the brain from recognizing […]
Abstract Orthopedic implant success hinges on effective osseointegration, which can be disrupted by early-stage inflammation and oxidative stress. This study introduces a novel peptide-based, inflammation-responsive coating designed to sequentially regulate immune response and promote bone regeneration. The coating consists of a self-assembling peptide hydrogel incorporating anti-inflammatory peptides linked via ROS-cleavable bonds and osteogenic peptides to […]
Abstract Multifunctional incretin peptides are revolutionizing the treatment landscape for type 2 diabetes and obesity. Unlike traditional therapies that target a single metabolic pathway, these innovative peptides are designed to activate multiple receptors—such as GLP-1, GIP, and glucagon—delivering synergistic effects on blood glucose control, weight loss, and overall metabolic health. Dual agonists like tirzepatide have […]
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are revolutionizing the management of metabolic diseases, offering powerful benefits that extend far beyond glucose control. Originally developed for type 2 diabetes, GLP-1RAs have demonstrated significant advantages in promoting weight loss, reducing cardiovascular risk, and now, treating liver conditions such as metabolic dysfunction-associated steatohepatitis (MASH). Backed by robust clinical […]
Abstract Relaxin-2, a hormone with well-documented roles in vascular and renal physiology, has demonstrated therapeutic potential in acute heart failure and renal dysfunction. However, the clinical utility of serelaxin, its recombinant form, is hindered by a short half-life and intravenous delivery requirements. R2R01, a novel single-chain peptide agonist of RXFP1, was developed to address these […]
LinkPeptide